E. R. SQUIBB & SONS, L.L.C.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 104152
 
  
 
C07K PEPTIDES 10149
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2475
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 21146
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS1236
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12194
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1188
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 445
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4134
 
  
 
C07D HETEROCYCLIC COMPOUNDS 4158

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0369,568 INTERFERON ALPHA ANTIBODIES AND THEIR USESAug 14, 17Dec 28, 17[A61K, C07K]
2017/0339,929 HCO32 AND HCO27 AND RELATED EXAMPLESJun 02, 17Nov 30, 17[C12N, A01K, C07K]
2017/0190,785 HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIESMar 17, 17Jul 06, 17[C07K]
2017/0158,767 HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)Jan 23, 17Jun 08, 17[A61K, C07K]
2016/0304,596 HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORSApr 22, 16Oct 20, 16[G01N, C07K]
2016/0257,753 HUMAN CTLA-4 ANTIBODIES AND THEIR USESMay 24, 16Sep 08, 16[C07K]
2012/0178,910 CATION EXCHANGE CHROMATOGRAPHY (METHODS)Sep 22, 10Jul 12, 12[C07K]
2011/0150,892 HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3) AND USES THEREOFAug 11, 09Jun 23, 11[A61K, C07H, C12P, C12N, A61P, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9765141 Methods for preparing interferon alpha antibodiesMar 21, 14Sep 19, 17[A61K, C07K]
9758593 Compositions and methods for treating cocaine-related disordersApr 20, 07Sep 12, 17[A61K, C07K]
9693539 HCO32 and HCO27 and related examplesAug 08, 08Jul 04, 17[C12P, C12N, A01K, C07K]
9631025 Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodiesAug 13, 15Apr 25, 17[C07H, A61K, C12P, C12N, C07K]
9580467 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofNov 12, 15Feb 28, 17[A61K, C07C, C07K]
9580505 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)Jul 23, 15Feb 28, 17[A61K, C07K]
9580507 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)Jun 21, 16Feb 28, 17[A61K, C07K]
9573999 CTLA-4 antibody dosage escalation regimensMay 18, 15Feb 21, 17[A61K, C07K]
9546216 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)Jul 23, 15Jan 17, 17[A61K, C07K]
9534053 Therapeutic human anti-IL-1R1 monoclonal antibodyMar 05, 14Jan 03, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0152,694 ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOFAbandonedOct 29, 15Jun 02, 16[C07K]
2015/0265,705 PD-1 ANTIBODIES IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND METHODS OF USE THEREOFAbandonedJun 08, 15Sep 24, 15[A61K]
2014/0302,581 METHODS FOR ENHANCED PROTEIN PRODUCTIONAbandonedJun 19, 14Oct 09, 14[C07K]
2014/0271,684 PD-1 ANTIBODIES IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND METHODS OF USE THEREOFAbandonedNov 12, 13Sep 18, 14[A61K]
2014/0234,331 HUMAN CTLA-4 ANTIBODIES AND THEIR USESAbandonedApr 28, 14Aug 21, 14[C07K]
2014/0179,904 PROTEIN PURIFICATION USING HCIC AND ION EXCHANGE CHROMATOGRAPHYAbandonedFeb 28, 14Jun 26, 14[C07K]
2013/0156,788 FULLY HUMAN ANTIBODIES SPECIFIC TO CADM1AbandonedDec 27, 12Jun 20, 13[C07K]
2011/0091,476 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway InhibitorsAbandonedSep 13, 10Apr 21, 11[A61K, C07H, C12N, G01N, A61P, C07K]
7465451 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferonExpiredDec 27, 06Dec 16, 08[A61K]
6962981 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigenExpiredApr 28, 00Nov 08, 05[C07K]
6787634 Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R).ExpiredFeb 02, 99Sep 07, 04[A61K, C07K]
5451580 Method for treating insult to neurons prone to Parkinson's degeneration employing an ATP-sensitive potassium channel blockerExpiredSep 22, 93Sep 19, 95[A61K]
5006344 Fosinopril tablet formulationsExpiredJun 26, 90Apr 09, 91[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.